Humacyte, Inc. (HUMA) has a market capitalization of $115.4M and trades at $0.74. The 52-week range is 0.547-2.93.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.8, Earnings Per Share (EPS) of $-0.26, annual revenue of $2.04M.
The stock has a beta of 2.11, operates in the Healthcare sector.
